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Case Report
ABSTRACT
Dysgerminoma is the most common malignant germ cell tumor in children and adolescents. Most cases occur in the 2nd and 3rd decades of life, but 
10% of cases occur in the 1st decade of life. The rarity of this malignancy in prepubertal children and the recognized controversies in its management 
prompted this case report. The case of a 6‑year‑old girl who had laparotomy and unilateral adnexectomy with subsequent histological diagnosis of an 
ovarian dysgerminoma was presented. Prognosis depends on the stage of the tumor at presentation, and conservative surgery should be the aim during 
the initial treatment. Adoption of multidisciplinary management within an oncology board with joint decision on the need for adjuvant chemotherapy for 
early stage diseases will confer good prognosis.
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Introduction
Solid ovarian tumors are uncommon in the pediatric 
population, but when occurred, they are a major source of 
anxiety for the patients and their family. Pediatric ovarian 
neoplasms account for an estimated incidence of 2.6 cases 
per 100,000 girls per year.[1] Ovarian malignancy in children 
and adolescents is reported in 10%–20% of all ovarian masses 
or neoplasms and comprises approximately 1%–2% of all 
childhood malignancies.[2] Dysgerminoma originates from 
undifferentiated germ cells that are similar to primordial germ 
cells, and it is identical to testicular seminoma. Two-third of 
malignant ovarian tumors in children and adolescents are 
germ cell tumors (GCTs).[3] Most cases occur in the 2nd and 
3rd decades of life, but 10% of cases occur in the 1st decade 
of life.[4] Most patients with dysgerminoma (75%) are 
diagnosed with early stage disease, and thus surgery alone 
is curative, and the prognosis is usually excellent,[5] but there 
is a significant dilemma with the management of advanced 
disease in children and adolescents. A rare case of ovarian 
dysgerminoma in a 6-year-old elementary school pupil who 
presented to the gynecological oncology clinic of our hospital 
is being reported. Information concerning the frequency and 
pattern of malignant ovarian tumors including dysgerminoma 
in children is scant in most Nigerian literatures. The rarity 
of this malignancy in prepubertal children in Nigeria and the 
recognized controversies in its management prompted us to 
report our experience.
Case Report
The patient was a 6-year-old girl who resided with her 
parents in Lagos, Southwest Nigeria. She was brought to 
the gynecological oncology clinic by her mother following 
a referral from a private hospital with a 3-week history of 
left-sided lower abdominal pain and progressive abdominal 
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swelling. Pain was insidious in onset, intermittent, dull in 
nature, and not severe enough to affect sleep or her daily 
activities. It was aggravated by sitting up and relieved by 
taking analgesics. Abdominal swelling was initially the size 
of an orange but progressively increased to reach the level 
of her navel. No history of chronic cough, but there was 
associated weight loss as evidenced by her clothes being 
oversized. There was no similar history in her siblings or 
parents. There was a history of vomiting of noncopious 
recently ingested meals on few occasions. The mother said 
her pregnancy was uneventful with no febrile illness or 
use of any unprescribed or illicit drugs during pregnancy. 
The child was delivered through spontaneous vaginal 
delivery at term at a private hospital. Pregnancy, labor, and 
puerperium were uneventful. Developmental milestones 
were attained at the appropriate times. An abdominopelvic 
computed tomography scan done on presentation at the 
referring hospital a week earlier was suggestive of a huge 
heterogeneous mass arising from the pelvis and extending 
superiorly into the abdomen. The mass was mainly solid 
with multiple areas within it. It had no calcifications within 
it and measured 12.5 cm × 8.10 cm × 7.5 cm [Figure 1]. 
Examination findings on presentation to us were that 
of a full abdomen with obvious suprapubic fullness and 
a 20-week sized abdominopelvic mass which was firm, 
non-tender, smooth, and mobile. Tumor markers including 
beta-human chorionic gonadotrophin and alpha-fetoprotein 
were essentially normal, but there was a 10-fold elevation 
in the level of lactate dehydrogenase (LDH). The findings 
and options of management were explained to the 
parents, and the child was planned for laparotomy and 
unilateral left adnexectomy (salpingo-oophorectomy) which 
she had 5 days later. Intraoperative findings [Figure 2] 
showed no ascitic fluid; a large left ovarian solid 
mass (15 cm × 12 cm × 10 cm) with grossly normal left 
tube; the right ovary and tube were also grossly normal; 
and minimal adhesion involving the left ovarian mass and 
omentum, otherwise the omentum was grossly normal. 
Her postoperative period was uneventful, and she was 
discharged home on the 4th postoperative day. The 
histological examination of the ovarian mass revealed 
a dysgerminoma with focal areas of necrosis without 
infiltration of the attached omentum. The child had no 
additional postoperative treatment and is currently being 
closely monitored with regular follow-up visits, physical 
examinations, ultrasound scan, and LDH assays. She has 
remained tumor-free for the past 3 years after her surgery.
Discussion
This report revealed the management outline of a 6-year-old 
Nigerian child with an ovarian dysgerminoma. Malignant 
neoplasms of the ovary in childhood are extremely rare and 
far less common than the benign ovarian tumors.[6] Ajani 
et al.[7] reported the rarity of childhood ovarian malignancies 
as only 24 cases of ovarian neoplasms were seen between the 
age group 0 and 14 years (<15 years of age) over a 22-year 
period (1991–2003) at University College Hospital, Ibadan. 
Dysgerminoma was found to be the most common primary 
malignant childhood ovarian tumor in Nigerian children,[7] and 
there was only one reported case in the Nigerian literature 
over the past 10 years (2006–2015).[8] These explain why there 
are only scattered reports on childhood ovarian malignancies 
in the literature and why there is a lack of specific pediatric 
treatment.
Ovarian lesions including malignancies can present with 
variable signs and symptoms, and most often, the clinical 
presentation does not differentiate benign tumor from a 
malignant tumor as found in the index case. Abdominal pain 
Figure 2: Intraoperative finding of ovarian dysgerminoma in the 6-year-old 
girl
Figure 1: Abdominopelvic computed tomography scan showing the huge 
complex adnexal mass in the 6-year-old child
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was the most common symptom encountered.[8] A mobile, 
palpable abdominal mass was the most frequent physical 
finding,[8] as we also observed in our patient. Elevated LDH 
can be an early clinical sign of an ovarian dysgerminoma. 
However, it is not all dysgerminomas that produce LDH, and 
this is often regarded as a nonspecific finding. Our patient 
had a 10-fold increase in her LDH levels.
The management of childhood ovarian tumor must be 
balanced with the desire to maintain the child’s reproductive 
and developmental potential. A definitive histologic 
diagnosis and a thorough understanding of the behavior of 
each of these tumors are necessary for appropriate therapy. 
Surgery is the initial step to obtain definitive diagnosis and 
provide initial treatment of patients with malignant ovarian 
GCTs.[9] Initial conservative management is, however, essential 
during this surgical treatment of pediatric ovarian tumors. 
A diagnosis from a frozen tissue section should not be used 
as the basis for radical surgery for a unilateral tumor in 
an otherwise unremarkable pelvis. If the lesion is a stage 
IA, just like in the index case, no postoperative therapy 
is indicated. However, if the dysgerminoma involves both 
ovaries, bilateral salpingo-oophorectomy and a full staging 
operation should be carried out; however, unless the uterus is 
involved by cancer, it should not be removed because in vitro 
fertilization with a donor ovum can be an option for the 
child in the future.[9] Metastatic disease demands complete 
cytoreductive surgery.
In the past, many stage I patients and all patients of higher 
stage were treated with radiotherapy because dysgerminomas 
have an inherently high degree of radiosensitivity. However, 
pelvic radiotherapy is associated with a high incidence of 
sterility, but with the development of effective chemotherapy 
regimens, radiotherapy is rarely indicated except for unusual 
metastatic patterns which is rarely seen in children. The current 
recommendation for adjuvant chemotherapy in the treatment 
of ovarian dysgerminoma is BEP (bleomycin, etoposide, and 
cisplatin).[10] This regimen has shown a sustained remission 
rate of 75%[9,10] and is currently the standard of care for the 
more advanced ovarian dysgerminoma in most centers 
including ours.[9]
The malignancy of pure dysgerminomas is relatively low 
grade, with survival rates of 80%–96%. The incidence of 
recurrence is, however, reportedly high, ranging between 
33% and 50% in some studies with most recurrences seen 
within the first 1 year after therapy with extreme rarity 
after 2 years.[10] Surveillance visits following active treatment 
should, therefore, consist of history, physical and pelvic 
examination, imaging, and relevant tumor markers quarterly 
for the fırst 2 years and biennially for 3 additional years. 
The index patient was also having postsurgery follow-up 
surveillance which will last for the next 5 years. There are 
still some disagreements regarding the optimal treatment 
of patients with dysgerminomas who received conservative 
surgical therapy in childhood and who later completed 
their desired childbearing. Exploratory laparotomy with 
a hysterectomy and salpingo-oophorectomy has been 
suggested for these patients. Because of the theoretical 
potential for late recurrences, the rarity of these tumors and 
the unknown benefit of this surgical intervention, however, 
most clinicians do not recommend this method of treatment.
Conclusion
Ovarian dysgerminomas are extremely uncommon in 
children. Pain and abdominal mass are the most common 
modes of presentation. Prognosis depends on the stage of 
the tumor at presentation, and conservative surgery should 
be the aim during the initial treatment in children and 
adolescents. Adoption of multidisciplinary management 
within an oncology board with joint decision on the need for 
adjuvant chemotherapy for early stage diseases will confer 
good prognosis.
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